Alterity Therapeutics Limited: December 2024 Form 6-K Financial Report Insights

Here are the key insights extracted from the provided section of the financial report for Alterity Therapeutics Limited:

1. Filing Type: This document is a Form 6-K, which is a report filed by foreign private issuers to disclose information that is material to investors.
2. Company Information:

• Name: Alterity Therapeutics Limited
• Address: Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia

3. Reporting Period: The report is for the month of December 2024.
4. Regulatory Context: The report is filed under the Securities Exchange Act of 1934, pursuant to rules 13a-16 or 15d-16.
5. Annual Reporting: The company indicates it will file annual reports under Form 20-F and has not opted for Form 40-F.
6. Incorporation by Reference: The Form 6-K is incorporated by reference into several Registration Statements on Form S-8 and Form F-3. This includes specific file numbers:

• Form S-8: 333-251073, 333-248980, 333-228671
• Form F-3: 333-274816, 333-251647, 333-231417, 333-250076

7. Exhibits Submitted:

• Exhibit 99.1: Notification regarding unquoted securities.

8. Signatory: The report is signed by Geoffrey P. Kempler, the Chairman of Alterity Therapeutics Limited.
9. Date of Signature: The document is dated December 31, 2024.

This information is critical for understanding the regulatory obligations and current status of Alterity Therapeutics Limited as a foreign private issuer in the financial markets. It also highlights the company's compliance with securities regulations and its reporting practices.